The management of antithrombotic agents for patients undergoing GI endoscopy.

By Ruben Acosta, N. Abraham, V. Chandrasekhara, Krishnavel V. Chathadi, D. Early, M. Eloubeidi, John A. Evans, A. Faulx, D. Fisher, Lisa Fonkalsrud and 11 more. Gastrointestinal Endoscopy, 2016

619 citations recorded by the source corpus.

Subfields: Gastroenterology, Pulmonary and Respiratory Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/49a44830d4820f24c948145d6aa323d42a4aa933

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. V. Chandrasekhara
2. M. Khashab
3. V. Muthusamy
4. A. Shaukat
5. R. Fanelli
6. D. Agrawal
7. D. Bruining
8. Ruben Acosta

Citations in the corpus

• Adverse events associated with ERCP. (2017, background): “Current guidelines suggest that low doses of aspirin or NSAIDs may be continued safely in the periendoscopic period.(75) Although the risk of bleeding associated with the use of a thienopyridine (ticlopidine, clopidogrel, and prasugrel) has not been well studied, it is recommended that these medicat”